Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Luc Janssens Added: 3 years ago
Chronic heart disease is the leading cause of death in both men and women in the US, and coronary artery disease (CAD) constitutes the number one cause among them. Acute ST-segment-elevation myocardial infarction (STEMI) usually occurs when a thrombus forms on a ruptured atheromateus plaque and occludes an epicardial coronary artery. Patient survival depends on several factors, the most important… View more

MI/ACS
Author(s): Pedro L Sánchez , Isaac Pascual Calleja , Héctor Bueno , et al Added: 3 years ago
The results of an electrocardiogram (ECG) on admission guide the next level of decision-making for the patient with chest pain suspected of myocardial ischaemia. If an occlusive thrombus forms, patients may develop an acute ST-segment-elevation myocardial infarction (STEMI), and the primary goal is to consider reperfusion therapy as quickly as possible. The benefit obtained by effective and early… View more

MI/ACS
Author(s): Joris van den Hurk Added: 3 years ago
Cardiovascular disease (CVD) is the most common cause of death worldwide.1 With an estimated 7.6 million global deaths due to coronary heart disease in 2005,2 the size of the burden placed on society cannot be understated. Acute myocardial infarction (AMI), the classic ‘heart attack,’ will be the classification given to many of these deaths. In its most life-threatening form, AMI is identified… View more

MI/ACS
Deferred Stenting for Heavy Thrombus Burden During PCI for STEMI
Author(s): Akshyaya Pradhan , Monika Bhandari , Pravesh Vishwakarma , et al Added: 3 years ago

MI/ACS
Job title: Interventional Cardiologist
Dr JamesMcCabe is anInterventional Cardiologist atUniversity of Washington Medical Center, Seattle, US. Hereceived his medical degree from Yale University. In 2013, Dr McCabe joined the University of Washington Medical Center and became medical director of the Cardiac Cath Labs in 2015 and subsequently was named Chief of Interventional Cardiology for the UW System in 2020. View more
Myocardial Infarction With Non-obstructive Coronary Arteries
Author(s): Sivabaskari Pasupathy , Rosanna Tavella , Simon McRae , et al Added: 3 years ago
Early coronary angiography performed during acute MI (AMI) identifies an occluded vessel in most patients with ST elevation MI (STEMI)1 and less frequently in those with non-STEMI;2 however, ≥90 % of patients with AMI have evidence of obstructive coronary artery disease.3 For these patients with overt coronary artery disease (CAD), the benefits of reperfusion strategies and cardioprotective… View more

Imaging & Diagnostics

Prevention & Chronic Conditions
Author(s): Ronald K Binder , Ahmed A Khattab Added: 3 years ago
The treatment of acute myocardial infarction (AMI) has substantially improved in recent decades. Thrombolysis, the former first-line therapy, which is inexpensive and may be administered without noteworthy delay in primary care or pre-hospital settings, has been replaced by primary percutaneous coronary intervention (PCI) despite the inherent delay of transfering patients to a cardiac… View more

Imaging & Diagnostics

MI/ACS
Author(s): Kristina Grønborg Laut , Alma Becic Pedersen , Timothy L Lash , et al Added: 3 years ago
Coronary heart disease (CHD) remains a leading cause of mortality and disability for both men and women in Europe, accounting for 1.92 million deaths each year.1 One in five women (22%) and one in five men (21%) die from the disease.1 This significant burden necessitates ongoing improvements in patient management and treatment, to minimise the impact of cardiovascular conditions on both patients… View more

MI/ACS

Intervention
ACC 22: Results from the GIPS-IV Trial
Author(s): Pim van der Harst , Added: 2 years ago
In this short interview from our coverage of the ACC.22 late-breaking trials, Dr Pim van der Harst and Dr Marie-Sophie de Koning (University Medical Center Groningen, NL) discuss the data from the GIPS-IV trial which investigates the safety and efficacy of the hydrogen sulfide (H2S) donor sodium thiosulfate (STS) in patients presenting with ST-segment elevation myocardial infarction (STEMI) … View more

MI/ACS
PCI Outcomes in Women
Author(s): Antonia Sambola , Bruno García Del Blanco , Vijay Kunadian , et al Added: 1 year ago

Vascular Disease and Surgery

MI/ACS